In the last trading session, 7.88 million shares of the uniQure N.V (NASDAQ:QURE) were traded, and its beta was 0.09. Most recently the company’s share price was $11.48, and it changed around -$4.41 or -27.75% from the last close, which brings the market valuation of the company to $628.29M. QURE currently trades at a discount to its 52-week high of $19.18, offering almost -67.07% off that amount. The share price’s 52-week low was $3.73, which indicates that the current value has risen by an impressive 67.51% since then.
uniQure N.V stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended QURE as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight. uniQure N.V is expected to report earnings per share of -0.93 for the current quarter.
uniQure N.V (NASDAQ:QURE) trade information
Instantly QURE has showed a red trend with a performance of -27.75% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 16.20 on recent trading dayincreased the stock’s daily price by 29.14%. The company’s shares are currently down -34.99% year-to-date, but still down -17.17% over the last five days. On the other hand, uniQure N.V (NASDAQ:QURE) is 28.12% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $27, which translates to bulls needing to increase their stock price by 57.48% from its current value. Analyst projections state that QURE is forecast to be at a low of $24 and a high of $30.
uniQure N.V (QURE) estimates and forecasts
The year-over-year growth rate is expected to be 40.22%, up from the previous year.
Consensus estimates provided by 10 financial analysts predict the company will bring in an average of 5.9M in revenue for the current quarter. 10 analysts expect uniQure N.V to make 6.67M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 7.87M and 10.32M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -25.08%. Forecasts for the next quarter put sales growth at -35.32%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.66%. uniQure N.V earnings are expected to increase by 20.69% in 2025, but the outlook is positive 33.41% per year for the next five years.
QURE Dividends
uniQure N.V’s next quarterly earnings report is expected to be released in June.
NANTAHALA CAPITAL MANAGEMENT, LLC, with 5.4511% or 2.65 million shares worth $11.87 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF and abrdn Healthcare Investors were the top two Mutual Funds as of Mar 31, 2025 . The former held 1.0 shares worth $11.51 million, making up 1.85% of all outstanding shares. On the other hand, abrdn Healthcare Investors held roughly 812.69 shares worth around $9.33 million, which represents about 1.50% of the total shares outstanding.
